Maxidex For Suspension
Product Images NDC 82667-600

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Maxidex (NDC 82667-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Max08 0000 01)

FDA Label Image

Figure (Max08 0000 02)

Figure (Max08 0000 02)
This text provides details about a prescription ophthalmic suspension called Maxidex, containing active ingredient dexamethasone 0.1%. It advises not to touch the dropper tip to prevent contamination and instructs to shake well before use. The storage instructions indicate it should be stored upright at a temperature range of 8°C to 27°C. The product details mention the presence of benzalkonium chloride 0.01% as a preservative and hypromellose 0.5% as a vehicle. It also lists other inactive ingredients and is distributed by Harrow Eye, LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.